(-)-demecolcine decreases expression ISO RGD:1605946 6480464 Demecolcine results in decreased expression of E2F8 mRNA CTD PMID:23649840 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane affects expression EXP 6480464 2 more ... CTD PMID:19414516 1,1-dichloroethene increases expression ISO RGD:1615757 6480464 vinylidene chloride results in increased expression of E2F8 mRNA CTD PMID:26682919 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of E2F8 mRNA CTD PMID:30723492 17alpha-ethynylestradiol affects expression ISO RGD:1615757 6480464 Ethinyl Estradiol affects the expression of E2F8 mRNA CTD PMID:17555576 17beta-estradiol increases expression ISO RGD:1605946 6480464 Estradiol results in increased expression of E2F8 mRNA CTD PMID:19167446 , PMID:20106945 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of E2F8 mRNA CTD PMID:32741896 17beta-estradiol multiple interactions ISO RGD:1605946 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of E2F8 mRNA CTD PMID:30165855 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of E2F8 mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1615757 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1615757 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1615757 6480464 Tetrachlorodibenzodioxin affects the expression of E2F8 mRNA CTD PMID:24058054 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of E2F8 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1605946 6480464 Tetrachlorodibenzodioxin affects the expression of E2F8 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1605946 6480464 Tetrachlorodibenzodioxin results in decreased expression of E2F8 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases methylation ISO RGD:1615757 6480464 Tetrachlorodibenzodioxin results in decreased methylation of E2F8 gene CTD PMID:21212295 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1615757 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of E2F8 mRNA, [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of E2F8 gene CTD PMID:16214954 , PMID:21212295 2,4-diaminotoluene increases expression ISO RGD:1615757 6480464 2, 4-diaminotoluene results in increased expression of E2F8 mRNA CTD PMID:20713471 2-butoxyethanol increases expression ISO RGD:1615757 6480464 n-butoxyethanol results in increased expression of E2F8 mRNA CTD PMID:19812364 3-methylcholanthrene increases expression ISO RGD:1615757 6480464 Methylcholanthrene results in increased expression of E2F8 mRNA CTD PMID:20713471 4-hydroxynon-2-enal decreases expression ISO RGD:1615757 6480464 4-hydroxy-2-nonenal results in decreased expression of E2F8 mRNA CTD PMID:19191707 5-fluorouracil affects expression ISO RGD:1605946 6480464 Fluorouracil affects the expression of E2F8 mRNA CTD PMID:16584549 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of E2F8 mRNA CTD PMID:24780913 7,12-dimethyltetraphene increases expression ISO RGD:1615757 6480464 9 more ... CTD PMID:32553695 aflatoxin B1 affects expression ISO RGD:1605946 6480464 Aflatoxin B1 affects the expression of E2F8 protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO RGD:1605946 6480464 Aflatoxin B1 results in increased methylation of E2F8 gene CTD PMID:28458013 aflatoxin B1 increases expression ISO RGD:1605946 6480464 Aflatoxin B1 results in increased expression of E2F8 mRNA CTD PMID:22100608 all-trans-retinoic acid decreases expression ISO RGD:1605946 6480464 Tretinoin results in decreased expression of E2F8 mRNA CTD PMID:23724009 , PMID:33167477 arsane decreases expression ISO RGD:1605946 6480464 Arsenic results in decreased expression of E2F8 mRNA CTD PMID:19945496 arsenic atom decreases expression ISO RGD:1605946 6480464 Arsenic results in decreased expression of E2F8 mRNA CTD PMID:19945496 arsenite(3-) multiple interactions ISO RGD:1605946 6480464 arsenite inhibits the reaction [G3BP1 protein binds to E2F8 mRNA] CTD PMID:32406909 arsenous acid decreases expression ISO RGD:1605946 6480464 Arsenic Trioxide results in decreased expression of E2F8 mRNA CTD PMID:26705709 atrazine decreases expression ISO RGD:1605946 6480464 Atrazine results in decreased expression of E2F8 mRNA CTD PMID:22378314 azathioprine decreases expression ISO RGD:1605946 6480464 Azathioprine results in decreased expression of E2F8 mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO RGD:1615757 6480464 Benzo(a)pyrene results in decreased expression of E2F8 mRNA CTD PMID:19770486 , PMID:32417428 benzo[a]pyrene increases expression ISO RGD:1605946 6480464 Benzo(a)pyrene results in increased expression of E2F8 mRNA CTD PMID:32234424 benzo[a]pyrene decreases expression ISO RGD:1605946 6480464 Benzo(a)pyrene results in decreased expression of E2F8 mRNA CTD PMID:20064835 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1605946 6480464 7 more ... CTD PMID:20382639 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1605946 6480464 7 more ... CTD PMID:26238291 benzo[b]fluoranthene increases expression ISO RGD:1615757 6480464 benzo(b)fluoranthene results in increased expression of E2F8 mRNA CTD PMID:26377693 bisphenol A decreases expression ISO RGD:1615757 6480464 bisphenol A results in decreased expression of E2F8 mRNA CTD PMID:21932408 bisphenol A affects methylation ISO RGD:1615757 6480464 bisphenol A affects the methylation of E2F8 promoter CTD PMID:27334623 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of E2F8 mRNA CTD PMID:25181051 bisphenol F decreases expression ISO RGD:1615757 6480464 bisphenol F results in decreased expression of E2F8 mRNA CTD PMID:30951980 butanal decreases expression ISO RGD:1605946 6480464 butyraldehyde results in decreased expression of E2F8 mRNA CTD PMID:26079696 cadmium atom decreases expression ISO RGD:1605946 6480464 Cadmium results in decreased expression of E2F8 mRNA CTD PMID:21120746 calcitriol decreases expression ISO RGD:1605946 6480464 Calcitriol results in decreased expression of E2F8 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1605946 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of E2F8 mRNA CTD PMID:21592394 camptothecin increases expression ISO RGD:1605946 6480464 Camptothecin results in increased expression of E2F8 mRNA CTD PMID:33770205 captan decreases expression ISO RGD:1615757 6480464 Captan results in decreased expression of E2F8 mRNA CTD PMID:31558096 carbamazepine affects expression ISO RGD:1605946 6480464 Carbamazepine affects the expression of E2F8 mRNA CTD PMID:25979313 carbon nanotube affects expression ISO RGD:1615757 6480464 Nanotubes, Carbon affects the expression of E2F8 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1615757 6480464 Nanotubes, Carbon analog results in increased expression of E2F8 mRNA CTD PMID:25554681 , PMID:25620056 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of E2F8 mRNA CTD PMID:18500788 choline multiple interactions ISO RGD:1615757 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of E2F8 mRNA CTD PMID:33549593 cisplatin increases expression ISO RGD:1605946 6480464 Cisplatin results in increased expression of E2F8 mRNA CTD PMID:27594783 clofibrate increases expression ISO RGD:1615757 6480464 Clofibrate results in increased expression of E2F8 mRNA CTD PMID:23811191 cobalt atom multiple interactions ISO RGD:1605946 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of E2F8 mRNA CTD PMID:23052192 copper atom multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of E2F8 mRNA CTD PMID:26033743 copper atom multiple interactions ISO RGD:1605946 6480464 [NSC 689534 binds to Copper] which results in decreased expression of E2F8 mRNA CTD PMID:20971185 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of E2F8 mRNA CTD PMID:26033743 copper(0) multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of E2F8 mRNA CTD PMID:26033743 copper(0) multiple interactions ISO RGD:1605946 6480464 [NSC 689534 binds to Copper] which results in decreased expression of E2F8 mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of E2F8 mRNA CTD PMID:26033743 copper(II) sulfate decreases expression ISO RGD:1605946 6480464 Copper Sulfate results in decreased expression of E2F8 mRNA CTD PMID:19549813 coumestrol increases expression ISO RGD:1605946 6480464 Coumestrol results in increased expression of E2F8 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1605946 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 crotonaldehyde decreases expression ISO RGD:1605946 6480464 2-butenal results in decreased expression of E2F8 mRNA CTD PMID:20471460 CU-O LINKAGE decreases expression ISO RGD:1605946 6480464 cupric oxide results in decreased expression of E2F8 mRNA CTD PMID:22077320 cyanocob(III)alamin multiple interactions ISO RGD:1615757 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of E2F8 mRNA CTD PMID:33549593 cyclosporin A decreases expression ISO RGD:1605946 6480464 Cyclosporine results in decreased expression of E2F8 mRNA CTD PMID:20106945 more ... cytarabine increases expression ISO RGD:1605946 6480464 Cytarabine results in increased expression of E2F8 mRNA CTD PMID:33770205 diarsenic trioxide decreases expression ISO RGD:1605946 6480464 Arsenic Trioxide results in decreased expression of E2F8 mRNA CTD PMID:26705709 dibenz[a,h]anthracene increases expression ISO RGD:1615757 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of E2F8 mRNA CTD PMID:21266533 dichloroacetic acid increases expression ISO RGD:1615757 6480464 Dichloroacetic Acid results in increased expression of E2F8 mRNA CTD PMID:28962523 dicrotophos increases expression ISO RGD:1605946 6480464 dicrotophos results in increased expression of E2F8 mRNA CTD PMID:28302478 dieldrin increases expression EXP 6480464 Dieldrin results in increased expression of E2F8 mRNA CTD PMID:23153324 dimethylselenide multiple interactions ISO RGD:1605946 6480464 [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of CSRP3-AS1 mRNA] which results in increased expression of E2F8 mRNA, [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of CSRP3-AS1 mRNA] which results in increased expression of E2F8 mRNA CTD PMID:33656867 dioxygen decreases expression ISO RGD:1605946 6480464 Oxygen deficiency results in decreased expression of E2F8 mRNA CTD PMID:26516004 dorsomorphin multiple interactions ISO RGD:1605946 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of E2F8 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1605946 6480464 Doxorubicin results in decreased expression of E2F8 mRNA CTD PMID:29803840 Enterolactone multiple interactions ISO RGD:1605946 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F8 mRNA CTD PMID:19167446 ethyl methanesulfonate increases expression ISO RGD:1605946 6480464 Ethyl Methanesulfonate results in increased expression of E2F8 mRNA CTD PMID:23649840 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of E2F8 mRNA CTD PMID:30307764 fluoranthene decreases expression ISO RGD:1615757 6480464 fluoranthene results in decreased expression of E2F8 mRNA CTD PMID:28329830 folic acid multiple interactions ISO RGD:1615757 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of E2F8 mRNA CTD PMID:33549593 folic acid decreases expression ISO RGD:1615757 6480464 Folic Acid results in decreased expression of E2F8 mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:1605946 6480464 Formaldehyde results in increased expression of E2F8 mRNA CTD PMID:23649840 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of E2F8 mRNA CTD PMID:33387578 geraniol decreases expression ISO RGD:1605946 6480464 geraniol results in decreased expression of E2F8 mRNA, geraniol results in decreased expression of E2F8 protein CTD PMID:27683099 glycine betaine multiple interactions ISO RGD:1615757 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of E2F8 mRNA CTD PMID:33549593 harmine increases expression ISO RGD:1605946 6480464 Harmine results in increased expression of E2F8 mRNA CTD PMID:25751815 heptachlor increases expression EXP 6480464 Heptachlor results in increased expression of E2F8 mRNA CTD PMID:23153324 hydroxyl multiple interactions ISO RGD:1605946 6480464 [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of CSRP3-AS1 mRNA] which results in increased expression of E2F8 mRNA CTD PMID:33656867 hydroxyurea increases expression ISO RGD:1605946 6480464 Hydroxyurea results in increased expression of E2F8 mRNA CTD PMID:33770205 iron atom increases expression ISO RGD:1605946 6480464 Iron deficiency results in increased expression of E2F8 mRNA CTD PMID:20368581 iron(0) increases expression ISO RGD:1605946 6480464 Iron deficiency results in increased expression of E2F8 mRNA CTD PMID:20368581 isotretinoin decreases expression ISO RGD:1605946 6480464 Isotretinoin results in decreased expression of E2F8 mRNA CTD PMID:20436886 kojic acid increases expression ISO RGD:1605946 6480464 kojic acid results in increased expression of E2F8 mRNA CTD PMID:16595896 L-methionine multiple interactions ISO RGD:1615757 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of E2F8 mRNA CTD PMID:33549593 Lasiocarpine multiple interactions ISO RGD:1605946 6480464 [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of E2F8 mRNA CTD PMID:33884520 Lasiocarpine increases expression ISO RGD:1605946 6480464 lasiocarpine results in increased expression of E2F8 mRNA CTD PMID:32234424 leflunomide decreases expression ISO RGD:1605946 6480464 leflunomide results in decreased expression of E2F8 mRNA CTD PMID:28988120 lipopolysaccharide decreases methylation ISO RGD:1615757 6480464 Lipopolysaccharides results in decreased methylation of E2F8 gene CTD PMID:21212295 lipopolysaccharide multiple interactions ISO RGD:1615757 6480464 [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of E2F8 gene CTD PMID:21212295 methotrexate increases expression ISO RGD:1605946 6480464 Methotrexate results in increased expression of E2F8 mRNA CTD PMID:33770205 methotrexate decreases expression ISO RGD:1605946 6480464 Methotrexate results in decreased expression of E2F8 mRNA CTD PMID:24657277 methyl methanesulfonate increases expression ISO RGD:1605946 6480464 Methyl Methanesulfonate results in increased expression of E2F8 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1605946 6480464 methylmercuric chloride results in decreased expression of E2F8 mRNA CTD PMID:28001369 monocrotaline multiple interactions ISO RGD:1605946 6480464 [CYP3A4 protein results in increased metabolism of Monocrotaline] which affects the expression of E2F8 mRNA CTD PMID:33884520 N-Nitrosopyrrolidine decreases expression ISO RGD:1605946 6480464 N-Nitrosopyrrolidine results in decreased expression of E2F8 mRNA CTD PMID:32234424 niclosamide decreases expression ISO RGD:1605946 6480464 Niclosamide results in decreased expression of E2F8 mRNA CTD PMID:28284560 nobiletin decreases expression ISO RGD:1605946 6480464 nobiletin results in decreased expression of E2F8 mRNA CTD PMID:23321314 nobiletin decreases expression EXP 6480464 nobiletin results in decreased expression of E2F8 mRNA CTD PMID:23321314 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of E2F8 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of E2F8 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1605946 6480464 [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of CSRP3-AS1 mRNA] which results in increased expression of E2F8 mRNA CTD PMID:33656867 paracetamol decreases expression ISO RGD:1605946 6480464 Acetaminophen results in decreased expression of E2F8 mRNA CTD PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of E2F8 mRNA CTD PMID:33387578 PCB138 multiple interactions ISO RGD:1615757 6480464 [2 more ... CTD PMID:25510870 perfluorononanoic acid decreases expression ISO RGD:1605946 6480464 perfluoro-n-nonanoic acid results in decreased expression of E2F8 mRNA CTD PMID:32588087 phenobarbital affects expression ISO RGD:1615757 6480464 Phenobarbital affects the expression of E2F8 mRNA CTD PMID:23091169 pirinixic acid increases expression ISO RGD:1615757 6480464 pirinixic acid results in increased expression of E2F8 mRNA CTD PMID:18301758 , PMID:23811191 progesterone decreases expression ISO RGD:1605946 6480464 Progesterone results in decreased expression of E2F8 mRNA CTD PMID:21795739 propanal decreases expression ISO RGD:1605946 6480464 propionaldehyde results in decreased expression of E2F8 mRNA CTD PMID:26079696 quinolin-8-ol decreases expression ISO RGD:1605946 6480464 Oxyquinoline results in decreased expression of E2F8 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1605946 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of E2F8 mRNA CTD PMID:19167446 riddelliine multiple interactions ISO RGD:1605946 6480464 [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of E2F8 mRNA CTD PMID:33884520 rotenone decreases expression ISO RGD:1605946 6480464 Rotenone results in decreased expression of E2F8 mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO RGD:1605946 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of E2F8 mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1605946 6480464 Silicon Dioxide analog results in decreased expression of E2F8 mRNA CTD PMID:23806026 silicon dioxide increases expression ISO RGD:1615757 6480464 Silicon Dioxide results in increased expression of E2F8 mRNA CTD PMID:29341224 silver atom decreases expression ISO RGD:1615757 6480464 Silver results in decreased expression of E2F8 mRNA CTD PMID:27131904 silver atom decreases expression ISO RGD:1605946 6480464 Silver results in decreased expression of E2F8 mRNA CTD PMID:26014281 silver(0) decreases expression ISO RGD:1615757 6480464 Silver results in decreased expression of E2F8 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1605946 6480464 Silver results in decreased expression of E2F8 mRNA CTD PMID:26014281 sodium arsenite increases expression ISO RGD:1605946 6480464 sodium arsenite results in increased expression of E2F8 mRNA CTD PMID:29301061 , PMID:34032870 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of E2F8 mRNA CTD PMID:22110744 sodium dodecyl sulfate increases expression ISO RGD:1605946 6480464 Sodium Dodecyl Sulfate results in increased expression of E2F8 mRNA CTD PMID:31734321 sodium fluoride increases expression ISO RGD:1615757 6480464 Sodium Fluoride results in increased expression of E2F8 mRNA CTD PMID:27862939 styrene increases expression ISO RGD:1615757 6480464 Styrene results in increased expression of E2F8 mRNA CTD PMID:28951217 succimer multiple interactions ISO RGD:1615757 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of E2F8 mRNA CTD PMID:21641980 sunitinib decreases expression ISO RGD:1605946 6480464 Sunitinib results in decreased expression of E2F8 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1615757 6480464 Tamoxifen affects the expression of E2F8 mRNA CTD PMID:17555576 testosterone multiple interactions ISO RGD:1605946 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of E2F8 mRNA CTD PMID:21592394 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of E2F8 mRNA CTD PMID:32741896 testosterone decreases expression ISO RGD:1605946 6480464 Testosterone results in decreased expression of E2F8 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:1615757 6480464 Carbon Tetrachloride results in increased expression of E2F8 mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of E2F8 mRNA CTD PMID:22659510 , PMID:34492290 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of E2F8 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of E2F8 mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:1615757 6480464 Trichloroethylene results in increased expression of E2F8 mRNA CTD PMID:28973375 trichostatin A affects expression ISO RGD:1605946 6480464 trichostatin A affects the expression of E2F8 mRNA CTD PMID:28542535 triclosan decreases expression ISO RGD:1605946 6480464 Triclosan results in decreased expression of E2F8 mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:1615757 6480464 trimellitic anhydride results in increased expression of E2F8 mRNA CTD PMID:19042947 tungsten decreases expression ISO RGD:1615757 6480464 Tungsten results in decreased expression of E2F8 mRNA CTD PMID:30912803 Tungsten carbide multiple interactions ISO RGD:1605946 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of E2F8 mRNA CTD PMID:23052192 tunicamycin decreases expression ISO RGD:1615757 6480464 Tunicamycin results in decreased expression of E2F8 mRNA CTD PMID:17127020 urethane decreases expression ISO RGD:1605946 6480464 Urethane results in decreased expression of E2F8 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1605946 6480464 Valproic Acid affects the expression of E2F8 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1605946 6480464 Valproic Acid results in increased expression of E2F8 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1605946 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of E2F8 mRNA CTD PMID:27188386 vincristine decreases expression ISO RGD:1605946 6480464 Vincristine results in decreased expression of E2F8 mRNA CTD PMID:23649840 zinc atom multiple interactions ISO RGD:1615757 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of E2F8 mRNA CTD PMID:33549593 zinc(0) multiple interactions ISO RGD:1615757 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of E2F8 mRNA CTD PMID:33549593